EUCTR2014-004613-93-Outside-EU/EEA进行中（未招募）不适用
Open label study to evaluate the effect, safety and tolerability of 250µg (8 MIU) interferon beta 1b (Betaferon) given subcutaneously every other day (for 24 weeks) in patients of Chinese origin with multiple sclerosis
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Chinese origin - diagnosis of Relapsing remitting multiple sclerosis or secondary progressive multiple sclerosis
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 35
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 18
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Any disease other than Multiple Sclerosis (MS) that could better explain the patients signs and symptoms - HIV (human immunodeficiency virus) infections - Hepatitis A - Syphilis - immunodeficiency - rheumatic disease or Sjogren syndrome - heart disease - severe depression - pregnancy or lactation - conditions interfering with Magnetic Resonance Imaging (MRI) - Gadolinium DTPA (Gadovist, contrast agent) allergy - allergy against human proteins, paracetamol, acetaminophen and ibuprofen intolerance - participation in other trial
研究者
相似试验
Unknown
2 期
A Clinical Study to evaluate the Safety and Efficacy of LP011-09 in subjects with Allergic RhinitisCTRI/2012/03/002473aila Pharmaceutical Pvt Ltd40
已完成
4 期
An open label study to evaluate the safety and efficacy of Aclasta (Zoledronic acid) in treatment of patients with Glucocorticoid induced OsteoporosisCTRI/2010/091/000637ovartis Healthcare Pvt Limited60
进行中（未招募）
1 期
A study to evaluate the safety and effect of CFZ533 on patients with Graves’ diseaseGraves' diseaseMedDRA version: 19.0Level: LLTClassification code 10018706Term: Graves' diseaseSystem Organ Class: 100000004860EUCTR2015-005564-41-DEovartis Pharma Services AG15
招募中
2 期
A study to investigate the safety and feasibility of delivering MDMA-assisted psychotherapy to patients with posttraumatic stress disorderPosttraumatic Stress DisorderMental Health - Other mental health disordersACTRN12623000838617Emyria Ltd5
进行中（未招募）
1 期
Open label study to assess the efficacy, safety and dosing of clevidipine in children undergoing surgery.EUCTR2013-001268-44-Outside-EU/EEAChiesi USA, Inc.80